The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.

@article{Moss2008TheIO,
  title={The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.},
  author={Alan C. Moss and Nielsen Q. Fernandez-Becker and K Jo Kim and D{\'i}dia H. Bismara Cury and Adam S. Cheifetz},
  journal={Alimentary pharmacology & therapeutics},
  year={2008},
  volume={28 2},
  pages={221-7}
}
BACKGROUND Little is known about long-term outcomes in patients who experience infusion reactions while receiving infliximab. AIM To investigate long-term outcomes in patients who experience infusion reactions while receiving infliximab. METHODS Retrospective electronic chart review of long-term clinical outcomes. RESULTS Clinical data on 287 patients who received infliximab infusions for Crohn's disease were reviewed, of whom 51 developed at least one infusion reaction (18%). Ileo… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
16 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…